Page 81 - Screening for Cervical Cancer: Systematic Evidence Review
P. 81

References



                              ThinPrep cervical cancer screening system. Acta Cytologica. 1998;42:209-213.

                 54.   Chock C, Irwig L, Berry G, Glasziou P. Comparing dichotomous screening tests when
                              individuals negative on both tests are not verified. J Clin Epidemiol.
                              1997;50:1211-1217.

                 55.   Kaufman RH, Schreiber K, Carter T. Analysis of atypical squamous (glandular) cells of
                              undetermined significance smears by neural network-directed review. Obstet
                              Gynecol. 1998;91:556-560.


                 56.   Jenny J, Isenegger I, Boon ME, Husain OA. Consistency of a double PAPNET scan of
                              cervical smears. Acta Cytologica. 1997;41:82-87.

                 57.   Kok MR, Boon ME, Schreiner-Kok PG, Koss LG. Cytological recognition of invasive
                              squamous cancer of the uterine cervix: comparison of conventional light-
                              microscopical screening and neural network-based screening. Hum Pathol.
                              2000;31:23-28.

                 58.   Wilbur DC, Bonfiglio TA, Rutkowski MA, et al. Sensitivity of the AutoPap 300 QC
                              System for cervical cytologic abnormalities.  Biopsy data confirmation. Acta
                              Cytol. 1996;40:127-132.


                 59.   Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ, Dax Taylor D. Detection of
                              high grade squamous intraepithelial lesions and tumors using the AutoPap
                              System: results of a primary screening clinical trial. Cancer. 1999;87:354-358.

                 60.   Duggan MA. Papnet-assisted, primary screening of cervico-vaginal smears. Eur J
                              Gynaecol Oncol. 2000;21:35-42.

                 61.   Petry KU, Bohmer G, Iftner T, Flemming P, Stoll M, Schmidt RE. Human
                              papillomavirus testing in primary screening for cervical cancer of human
                              immunodeficiency virus-infected women, 1990-1998. Gynecol Oncol.
                              1999;75:427-431.


                 62.   Womack SD, Chirenje ZM, Blumenthal PD, et al. Evaluation of a human papillomavirus
                              assay in cervical screening in Zimbabwe. Br J Obstetr Gynaecol. 2000;107:33-38.


                 63.   Womack SD, Chirenje ZM, Gaffikin L, et al. HPV-based cervical cancer screening in a
                              population at high risk for HIV infection. Int J Cancer. 2000;85:206-210.


                 64.   Wright TCJ, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected
                              vaginal samples compared with cytologic screening to detect cervical cancer.
                              JAMA. 2000;283:81-86.

                 65.   Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer
                              screening: results from women in a high-risk province of Costa Rica. J Am Med
                              Assoc. 2000;283:87-93.





                                                             87
   76   77   78   79   80   81   82   83   84   85   86